One Weeklong Insulin Patch Could Replace Up to 21 Mealtime Shots

CeQur’s updated Simplicity insulin patch is now available in the US, offering seven-day wear and the potential to replace up to 21 mealtime injections.

Written By
Liz Ticong
Liz Ticong
Nov 11, 2026
One Weeklong Insulin Patch Could Replace Up to 21 Mealtime Shots

CeQur’s updated Simplicity insulin patch is now available in the U.S. with up to seven days of wear, offering adults who take mealtime insulin a way to reduce repeated daily injections. Image generated with Google’s Nano Banana.

Three meals a day can mean three insulin injections. Multiply that by seven days, and that’s up to 21 encounters with a needle every week. A newly upgraded wearable patch could make that routine a little less demanding.

Medical technology company CeQur announced Nov. 10 that its updated Simplicity insulin patch is now available nationwide in the US. Designed for adults who need mealtime insulin, the device can be worn for up to seven days, delivering prescribed doses with the press of two buttons instead of repeated needle injections.

That’s potentially 21 fewer shots to prepare, whether at home, at work, or on the go. The patch doesn’t eliminate the need to manage insulin doses, but it could make one of the more repetitive parts of diabetes care a little simpler.

A button-operated system delivers insulin beneath the skin

CeQur Simplicity is a disposable patch filled with prescribed rapid-acting insulin. An inserter places a small, flexible tube called a cannula beneath the skin, allowing users to administer doses by pressing two buttons without preparing another syringe or pen.

Advertisement

Unlike sensor-connected insulin pumps, the device operates mechanically without batteries or software. It also does not measure blood sugar like wearable glucose monitors.

According to the manufacturer, the updated patch introduces several improvements over its predecessor.

FeaturePrevious patchUpdated patch
Wear durationUp to 4 daysUp to 7 days
Dosing increments2 units1-unit or 2-unit versions
Insulin capacity200 units240 units

Replacing three mealtime injections daily for seven days produces the company’s maximum estimate of 21 avoided shots. Actual wear time depends on insulin consumption.

Available by prescription, Simplicity supports adults older than 21 with type 1 or type 2 diabetes who use U-100 Humalog or NovoLog for mealtime insulin.

Patient surveys and clinical trials examine insulin delivery outcomes

A new CeQur/Harris Poll survey of 409 US adults using pens or syringes for mealtime insulin found several difficulties with their treatment routines.

  • 51% reported missing or skipping insulin doses.
  • 52% said they did not always carry insulin supplies when leaving home.
  • 70% of respondents who had missed doses and answered the public-setting question said they had missed a dose because they were in public.
Advertisement

Previous research also examined how wearable insulin delivery compares with conventional injections. A 2019 randomized trial involving 278 adults with type 2 diabetes tested an earlier three-day patch against insulin pens.

After 24 weeks, average HbA1c levels, which measure longer-term blood sugar control, fell by 1.7 percentage points among patch users and 1.6 points among pen users. Researchers found no significant difference in adverse events, although participants using the patch reported greater satisfaction with their treatment.

A weeklong insulin patch could reduce interruptions at work

Working adults who take insulin during long shifts or between meetings could benefit from a device that allows them to administer doses without preparing an injection in public.

Keeping medication accessible throughout the day could also reduce interruptions during travel, when finding a suitable place to inject may be inconvenient.

Patients would still need to calculate their prescribed doses and maintain accurate administration records. Even people who receive glucose readings on a smartwatch must manage insulin delivery separately, since the patch cannot respond automatically to those measurements. Any prescribed background insulin treatment also remains necessary.

Advertisement

Before switching, patients should discuss the available dosing increments, insulin capacity, and suitability of the device with their healthcare professional.

They should also confirm insurance coverage, prescription requirements, and how to manage situations such as early insulin depletion or patch detachment.

For existing Simplicity users, the longer wear time applies to the updated device rather than older four-day patches. Patients should confirm the appropriate product and replacement schedule before making any changes.

The updated patch could make mealtime insulin delivery more convenient, but its value will depend on how well it fits each person’s treatment needs and daily routine.

Related reading: Tracking blood pressure and blood sugar is getting more convenient as Google Health introduces new logging tools and glucose charts.

Liz Ticong

Liz Ticong is a technology writer specializing in artificial intelligence, cybersecurity, software reviews, and emerging business technologies. With more than a decade of professional writing experience and over five years contributing technology content for TechnologyAdvice, she helps readers understand complex technologies and evaluate the tools that best fit their needs. Liz has extensive experience researching, testing, and analyzing software platforms, AI tools, and technology solutions. Her work includes in-depth software reviews, buyer’s guides, product comparisons, and technology news coverage designed to help businesses make informed purchasing and implementation decisions. She regularly evaluates AI applications, automation tools, cybersecurity solutions, and business software, providing practical insights based on hands-on testing and research. In addition to her work with TechnologyAdvice, Liz has contributed technology content to leading industry publications, including eWeek and TechRepublic. Her background in technical writing and software analysis enables her to translate complex technical concepts into clear, actionable guidance for both business and technology audiences. Liz holds a bachelor's degree in Broadcast Communication from the Polytechnic University of the Philippines and continues to expand her expertise through ongoing education in artificial intelligence and emerging technologies. Through her writing, she helps readers navigate a rapidly evolving technology landscape with practical, research-driven insights and real-world product analysis.